ACPE UAN #: 0233-0000-20-029-H04-P
Release Date: April 23, 2020
Expiration Date: April 23, 2023
Activity Type: Knowledge-based
Contact Hours: 1.0 contact hours
Activity Fee: Member: Free Non-Member: $30
Target Audience: Pharmacists who practice in managed care settings.
Cancer is one of the world’s most pressing health care challenges, with more than 14 million people receiving a cancer diagnosis each year. That said, significant biopharmaceutical advances have been made across the spectrum of cancers in the past decade. The death rate from cancer in the United States has declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop ever recorded, according to annual statistics reported by American Cancer Society. However, the downstream impact of recent innovation has led to significant increases in drug spending, which is expected to reach $600 billion in 2023. In order to sustain access to these innovative therapies, new reimbursement models are needed to balance risks between payors and manufacturers, including the use of innovative value-based or outcome-based contracting strategies.
This session will review the most impactful advances in cancer research, highlighting advances that truly show progress against cancer. While costs will be highlighted, the focus of this presentation will be balancing value, cost and risk with the consideration of continuous rise in oncology innovation. Participants will recognize what value-based reimbursement models are currently available and leave prepared to apply these principles to their own reimbursement policies.
At the completion of this activity, participants should be able to:
1. Recognize the current spend and advances in cancer treatment that will guide the market in the next five years.
2. Discuss the potential value- and outcome-based strategies to address the rapidly rising cost of cancer agents.
3. Identify other opportunities in oncology to help offset the rising cost of innovation.
Schedule of Educational Activity
This activity consists of an audio recording, pre-test assessment questions (not required to pass to continue), post-test questions (required to pass with a score of 70% or higher) and a specific activity evaluation.
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live webinar activity presented at AMCP eLearning Days.
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for continuing education online learning activities.
As an accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of continuing pharmacy education (CPE) activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.
Nicholas Ladikos, Director, Professional Affairs, AMCP, Alexandria, Virginia
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-20-029-H04-P||1 Contact Hour||April 23, 2020 - April 23, 2023|